NEKTAR THERAPEUTICS

NKTR · NASDAQ

Pharmaceutical Preparation Manufacturing · US

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.

Market Data

Price $59.38 +0.17 (+0.29%)

Market Cap$2.01B

P/E Ratio—

EPS$—

52W High$109.00

52W Low$7.99

Beta1.15

Data from Finnhub · Updated Jun 15, 2026